InsPro Technologies Corp Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 51 rows, 51 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-04-01: Reporting owner Independence Health Group, Inc. | AmeriHealth, Inc. | Independence Blue Cross, LLC; Form 4; Security Series B Convertible Preferred Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-02-03: Reporting owner Majesco; Form 3; Security Series A Preferred Stock, par value $0.001; Transaction Holding.
- 2020-02-03: Reporting owner Majesco; Form 3; Security Series B Preferred Stock, par value $0.001; Transaction Holding.
- 2020-02-03: Reporting owner Majesco; Form 3; Security Series C Preferred Stock, par value $0.001; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-04-01 | Independence Health Group, Inc. | AmeriHealth, Inc. | Independence Blue Cross, LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500,000 0 owned after | no price filed | 2020-04-03 | |
| 2020-02-03 holding as of filing | Majesco 10% Owner | 3 | Series A Preferred Stock, par value $0.001 Derivative · Indirect · "See notes 1,2 and 3 in ""Explanation of Responses"" below." | Holding | no price filed | 2020-02-03 | ||
| 2020-02-03 holding as of filing | Majesco 10% Owner | 3 | Series B Preferred Stock, par value $0.001 Derivative · Indirect · "See notes 1,2 and 3 in ""Explanation of Responses"" below." | Holding | no price filed | 2020-02-03 | ||
| 2020-02-03 holding as of filing | Majesco 10% Owner | 3 | Series C Preferred Stock, par value $0.001 Derivative · Indirect · "See notes 1,2 and 3 in ""Explanation of Responses"" below." | Holding | no price filed | 2020-02-03 | ||
| 2017-04-20 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series C Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $2.00 | 2017-04-26 | |
| 2016-05-13 holding as of filing | Trustmark Mutual Holding Co | Trustmark Group, Inc. | Trustmark Insurance Group, Inc. | TRUSTMARK INSURANCE CO 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · See footnote 2 | Holding | $3.00 exercise price | 2016-05-13 | ||
| 2015-10-23 holding as of filing | Azeez Michael Director | 3 | Series B Convertible Preferred Stock Non-derivative · Indirect · Footnote | Holding | 283,333 owned after | no price filed | 2015-10-23 | |
| 2015-10-23 holding as of filing | Azeez Michael Director | 3 | Series B Convertible Preferred Stock Non-derivative · Indirect · Footnote | Holding | 150,000 owned after | no price filed | 2015-10-23 | |
| 2015-10-23 holding as of filing | Azeez Michael Director | 3 | Warrant to Purchase Series B Convertible Preferred Stock Derivative · Direct · (m) | Holding | $3.00 exercise price | 2015-10-23 | ||
| 2015-10-06 | Independence Health Group, Inc. | Independence Blue Cross, LLC | AmeriHealth, Inc. Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | P Open market or private purchase of non-derivative or derivative security | +333,333 2,500,000 owned after | no price filed | 2015-10-08 | |
| 2015-09-18 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +696,475 1,827,186 owned after | no price filed | 2015-10-23 | |
| 2015-09-18 | Walters Edmond Director | 4 | Series B Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +166,666 3,333,320 owned after | no price filed | 2015-10-23 | |
| 2014-08-14 | Independence Blue Cross, LLC | Independence Health Group, Inc. | AmeriHealth, Inc. Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series B Preferred Stock Warrant (Right to Buy) Derivative · Indirect · See Footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-08-18 | |
| 2014-07-10 holding as of filing | Independence Blue Cross, LLC | Independence Health Group, Inc. | AmeriHealth, Inc. 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2014-07-10 | ||
| 2014-07-01 | Independence Blue Cross 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | J Other acquisition or disposition (describe transaction) | −2,166,667 0 owned after | $0.00 | 2014-07-03 | |
| 2014-05-22 | Walters Edmond Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-06-19 | |
| 2014-05-22 | ROWELL LJ JR Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | Verdi Anthony Director, Officer (CEO,CFO,COO) | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | Soltoff Paul Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | Rich Sanford Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | Oakes Robert J Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | Harrison John Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 60,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2014-05-22 | Harvey Kenneth M Director | 4 | Series B Preferred Stock Warrant (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $3.00 exercise price | 2014-06-18 | |
| 2013-09-12 | Independence Blue Cross 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +500,000 43,333,340 owned after | no price filed | 2013-09-13 | |
| 2012-11-20 | Tecce Frederick C. Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +333,333 22,614,220 owned after | no price filed | 2012-11-30 | |
| 2012-11-20 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +333,333 22,614,220 owned after | no price filed | 2012-11-30 | |
| 2012-11-20 | CALDWELL DONALD R Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +333,333 22,614,220 owned after | no price filed | 2012-11-30 | |
| 2010-12-22 | Tecce Frederick C. Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +797,378 15,947,560 owned after | no price filed | 2010-12-27 | |
| 2010-12-22 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +797,378 15,947,560 owned after | no price filed | 2010-12-27 | |
| 2010-12-22 | CALDWELL DONALD R Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +797,378 15,947,560 owned after | no price filed | 2010-12-27 | |
| 2010-11-29 | Independence Blue Cross 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +0 33,333,340 owned after | no price filed | 2010-12-01 | |
| 2010-10-07 holding as of filing | Independence Blue Cross 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2010-10-07 | ||
| 2010-08-18 | Oakes Robert J Director | 4 | Warrant to Purchase Series A Convertible Preferred Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $4.00 exercise price | 2010-08-27 | |
| 2010-03-26 | Verdi Anthony Director, Officer (CFO and COO) | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,250 1,250 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | Tecce Frederick C. Director, 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +250,000 1,250,000 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | Soltoff Paul Director | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,250 1,250 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | Rich Sanford Director | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,250 1,250 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | Oakes Robert J Director | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,250 1,250 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | Harrison John Director | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,250 1,250 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +250,000 1,250,000 owned after | no price filed | 2010-03-30 | |
| 2010-03-26 | CALDWELL DONALD R Director, 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +250,000 1,250,000 owned after | no price filed | 2010-03-30 | |
| 2009-01-15 | CALDWELL DONALD R Director, 10% Owner | 4/A | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4.00 | 2009-11-02 | |
| 2009-01-15 | CALDWELL DONALD R Director, 10% Owner | 4/A | Warrant to Purchase Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4,000,000.00 | 2009-11-02 | |
| 2009-01-15 | Tecce Frederick C. Director, 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4.00 | 2009-01-20 | |
| 2009-01-15 | Tecce Frederick C. Director, 10% Owner | 4 | Warrant to Purchase Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4,000,000.00 | 2009-01-20 | |
| 2009-01-15 | CALDWELL DONALD R Director, 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4.00 | 2009-01-20 | |
| 2009-01-15 | CALDWELL DONALD R Director, 10% Owner | 4 | Warrant to Purchase Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4,000,000.00 | 2009-01-20 | |
| 2009-01-15 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4.00 | 2009-01-20 | |
| 2009-01-15 | CO-INVESTMENT FUND II, L.P. 10% Owner | 4 | Warrant to Purchase Series A Convertible Preferred Stock Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,000,000 1,000,000 owned after | $4,000,000.00 | 2009-01-20 |